Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology

Journal of Refractive Surgery

Volumn 28, Issue 10, 2012, Pages 706-713

  Price, Marianne O ^a   Tenkman, Lawrence R ^b   Schrier, Amilia ^c   Fairchild, Kelly M ^a   Trokel, Stephen L ^c   Price, Francis W ^b  

^a Lautert)   (United States)

^b PRICE VISION GROUP   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COLLAGEN; MEDIOCROSS; RIBOFLAVIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL KERATITIS; BACTERIUM CULTURE; CLINICAL ARTICLE; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA PERFORATION; CORNEA TRANSPLANTATION; DRUG INSTILLATION; FEMALE; FUNGUS CULTURE; HERPES SIMPLEX KERATITIS; HUMAN; INFECTIOUS KERATITIS; INFLAMMATORY INFILTRATE; KERATITIS; KERATOMYCOSIS; MALE; MULTICENTER STUDY; PARASITE IDENTIFICATION; PENETRATING KERATOPLASTY; PHOTOACTIVATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN CROSS LINKING; PROTOZOAL KERATITIS; RISK ASSESSMENT; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; VIRUS CULTURE; VIRUS KERATITIS;

EID: 84870170939     PISSN: 1081597X     EISSN: 19382391     Source Type: Journal    
DOI: 10.3928/1081597X-20120921-06     Document Type: Article

References (22)

1. Price FW Jr, Whitson WE, Gonzales J, Johns S. Corneal tissue levels of topically applied ofloxacin. J Cataract Refract Surg. 1997;23(6):898-902. (Pubitemid 27375307)
2. Tsugita A, Okada Y, Uchara K. Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochim Biophys Acta. 1965;103(2):360-363.
3. Goodrich RP. The use of riboflavin for inactivation of pathogens in blood products. Vox Sang. 2000;78(Suppl 2):211-215.
4. Martins SA, Combs JC, Noguera G, et al. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008;49(8):3402-3408.
5. Schrier A, Greebel G, Attla H, Trokel S, Smith EF. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J Refract Surg. 2009;25(9):S799-S802.
6. Makdoumi K, Mortensen J, Sorkhabi O, Malmvall BE, Crafoord S. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):95-102.
7. Anwar HM, El-Danasoury AM, Hashem AN. Corneal collagen crosslinking in the treatment of infectious keratitis. Clin Ophthalmol. 2011;5:1277-1280.
8. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620-627. (Pubitemid 36457967)
9. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29(1):35-40. (Pubitemid 39389439)
10. Schnitzler E, Spörl E, Seiler T. Irradiation of cornea with ultraviolet light and riboflavin administration as a new treatment of erosive corneal processes, preliminary results in four patients [German]. Klin Monbl Augenheikd. 2000;217(3):190-193.
11. Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27(5):590-594.
12. Makdoumi K, Mortensen J, Crafoord S. Infectious keratitis treated with corneal crosslinking. Cornea. 2010;29(12):1353-1358.
13. Al-Sabai N, Koppen C, Tassignon MJ. UVA/riboflavin crosslinking as treatment for corneal melting. Bull Soc Belge Ophthalmol. 2010;(315):13-17.
14. Kymionis GD, Kankariya VP, Kontadakis GA. Combined treatment with flap amputation, phototherapeutic keratectomy, and collagen crosslinking in severe intractable post-LASIK atypical mycobacterial infection with corneal melt. J Cataract Refract Surg. 2012;38(4):713-715.
15. Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26(4):385-389. (Pubitemid 46684375)
16. Galperin G, Berra M, Tau J, Boscaro G, Zarate J, Berra A. Treatment of fungal keratitis from Fusarium infection by corneal cross-linking. Cornea. 2012;31(2):176-180.
17. Ehlers N, Hjortdal J, Nielsen K, Sondergaard A. Riboflavin-UVA treatment in the management of edema and nonhealing ulcers of the cornea. J Refract Surg. 2009;25(9):S803-S806.
18. Kashiwabuchi RT, Carvalho FR, Khan YA, et al. Assessing effi cacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Invest Ophthalmol Vis Sci. 2011;52(13):9333-9338.
19. del Buey MA, Cristobal JA, Casas P, et al. Evaluation of in vitro efficacy of combined riboflavin and ultraviolet A for Acanthamoeba isolates. Am J Ophthalmol. 2012;153(3):399-404.
20. Khan YA, Kashiwabuchi RT, Martins SA, et al. Riboflavin and ultraviolet light A therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology. 2011;118(2):324-331.
21. Garduno-Vieyra L, Gonzalez-Sanchez CR, Hernandez-Da Mota SE. Ultraviolet-a light and riboflavin therapy for Acanthamoebe keratitis: a case report. Case Report Ophthalmol. 2011;2(2):291-295.
22. Kymionis GD, Portaliou DM, Bouzoukis DI, et al. Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg. 2007;33(11):1982-1984. (Pubitemid 47628804)